Drug Intervention Can Correct Subnormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy von Berkowitz, Bruce A, Roberts, Robin, Luan, Hongmei, Peysakhov, Jamie, Knoerzer, Deborah L, Connor, Jane R, Hohman, Thomas C

Volltext

Regulation of the Early Subnormal Retinal Oxygenation Response in Experimental Diabetes by Inducible Nitric Oxide Synthase von BERKOWITZ, Bruce A, HONGMEI LUAN, KERN, Timothy S, ITO, Yasuki, GUPTA, Rita R, PACHECO, Daniel, SEIDNER, Andres, ROBERTS, Robin, LIGGETT, Jessica, KNOERZER, Deborah L, CANNER, Jane R, YUNPENG DU

Volltext

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models von Sigaud, Romain, Rösch, Lisa, Gatzweiler, Charlotte, Benzel, Julia, von Soosten, Laura, Peterziel, Heike, Selt, Florian, Najafi, Sara, Ayhan, Simay, Gerloff, Xenia F, Hofmann, Nina, Büdenbender, Isabel, Schmitt, Lukas, Foerster, Kathrin I, Burhenne, Jürgen, Haefeli, Walter E, Korshunov, Andrey, Sahm, Felix, van Tilburg, Cornelis M, Jones, David T W, Pfister, Stefan M, Knoerzer, Deborah, Kreider, Brent L, Sauter, Max, Pajtler, Kristian W, Zuckermann, Marc, Oehme, Ina, Witt, Olaf, Milde, Till

Volltext